Scientific publications
Scientific publications of the Veneto Tumour Registry
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli A, Cuccaro F, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino M, Carrozzi G, Stracci F, Michiara M, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Rizzello RV, Mian M, Cascone G, Boschetti L, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Dal Maso L; AIRTUM Working Group. Front Oncol. 2023 Jun 6;13:1168325. doi: 10.3389/fonc.2023.1168325. eCollection 2023. Abstract...
Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas.
Buja A, Rugge M, Barillaro M, Miatton A, Tropea S, Cozzolino C, Zorzi M, Vecchiato A, Del Fiore P, Brunello A, Baldo V, Rossi CR, Mocellin S. Oncol Lett. 2023 May 26;26(1):301. doi: 10.3892/ol.2023.13887. eCollection 2023 Jul. Abstract Retroperitoneal soft-tissue sarcomas (RPS) are rare forms of mesenchymal tumors that account for ~0.15% of all malignancies. The purpose of the present study was to determine the differences between RPS and non-RPS anatomopathological and clinical features and to analyze whether the hazard ratio for short-term mortality differs between patients with RPS and...
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group. Front Oncol. 2023 Apr 24;13:1114701. doi: 10.3389/fonc.2023.1114701. eCollection 2023. Abstract Introduction: Comparable indicators on complete cancer prevalence are increasingly needed in Europe to support survivorship care planning. Direct measures can be biased by limited registration time and estimates are needed to recover long term survivors. The completeness index method, based on incidence and survival modelling, is the standard most validated...
Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990-2015)
Mancini S, Bucchi L, Zamagni F, Baldacchini F, Crocetti E, Giuliani O, Ravaioli A, Vattiato R, Preti M, Tumino R, Ferretti S, Biggeri A, Ballotari P, Boschetti L, Brustolin A, Caldarella A, Cavallo R, Cirilli C, Citarella A, Contrino ML, Dal Maso L, Filiberti RA, Fusco M, Galasso R, Lotti FL, Magoni M, Mangone L, Masanotti G, Mazzoleni G, Mazzucco W, Melcarne A, Michiara M, Pesce P, Pinto A, Piras D, Rizzello RV, Rognoni M, Rosso S, Rugge M, Sampietro G, Scalzi S, Scuderi T, Tagliabue G, Toffolutti F, Vitarelli S, Falcini F; AIRTUM Working Group. J Clin Med. 2023 Mar 10;12(6):2172. doi:...
Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study
Zorzi M, Antonelli G, Amidei CB, Battagello J, Germanà B, Valiante F, Benvenuti S, Tringali A, Bortoluzzi F, Cervellin E, Giacomin D, Meggiato T, Rosa-Rizzotto E, Fregonese D, Dinca M, Baldassarre G, Scalon P, Pantalena M, Ann Intern Med. 2023 Feb 21. doi: 10.7326/M22-1008. AbstractBackground: Colorectal cancer (CRC) screening programs based on fecal immunochemical tests (FITs) represent the standard of care for population-based interventions. Their benefit depends on the identification of neoplasia at colonoscopy after FIT positivity. Colonoscopy quality measured by adenoma detection rate...
Machine learning to predict overall short-term mortality in cutaneous melanoma
Cozzolino C, Buja A, Rugge M, Miatton A, Zorzi M, Vecchiato A, Del Fiore P, Tropea S, Brazzale A, Damiani G, dall'Olmo L, Rossi CR, Mocellin S. Discov Oncol. 2023 Jan 31;14(1):13. doi: 10.1007/s12672-023-00622-5. AbstractBackground: Cutaneous malignant melanoma (CMM) ranks among the ten most frequent malignancies, clinicopathological staging being of key importance to predict prognosis. Artificial intelligence (AI) has been recently applied to develop prognostically reliable staging systems for CMM. This study aims to provide a useful machine learning based tool to predict the overall CMM...
The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020
Giorgi Rossi P, Carrozzi G, Falini P, Sampaolo L, Gorini G, Zorzi M, Armaroli P, Senore C, Sassoli de Bianchi P, Masocco M, Zappa M, Battisti F, Mantellini P. Elife. 2023 Feb 3;12:e81804. doi: 10.7554/eLife.81804. AbstractBackground: In Italy, regions have the mandate to implement population-based screening programs for breast, cervical, and colorectal cancer. From March to May 2020, a severe lockdown was imposed due to the COVID-19 pandemic by the Italian Ministry of Health, with the suspension of screening programs. This paper describes the impact of the pandemic on Italian screening...
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records
Gion M, De Gobbi R, Zorzi M, Carretta G, Leonardi L, Guzzinati S, Trevisiol C, Cancian M, Cardinali G, Michieletto F, Dittadi R, Fabricio ASC, Rugge M, Russo F. Int J Biol Markers. 2023 Feb 28:3936155231154663. doi: 10.1177/03936155231154663. AbstractPurpose: The overuse of laboratory tests contributes to impair health systems effectiveness, tumor markers (TMs) being a paradigmatic example. In the present study we applied indicators of TMs appropriateness developed from administrative datasets to appraise regionwide overordering in the clinical practice. Patients and methods: TMs ordered to...
Main topics
Scientific publications
Scientific publications of the Veneto Tumour Registry
Monographs
Reports by tumour site and monographs.
Congress and conference
Discover all the oral publications and posters.